@atomicaceso @psychgeist52 If you’re going to read one thing, though, read this— Cochrane reviews are less biased. https://t.co/oMHWIi3s8Z
@eisenlohr_moul @atomicaceso @psychgeist52 ..evidence (old) quite hard to evaluate: "..overall quality of the evidence was rated low to moderate, main weakness being poor reporting of methods in the included studies. *At least 21 of the studies received
Inhibidores selectivos de la recaptación de serotonina para el síndrome premenstrual...👇
@Gaz__97 Un revue de 2013 concluait à une efficacité dans le syndrome prémenstruel : https://t.co/eDRtzRNjh7
@atomicaceso @recover2renew Hmm. Evidence to consider, thanks to @johndrummond33 https://t.co/tl29no9XUj
@shvogt Its taken as read that they are effective, this just looked at 2 dosing methods. The evidence for efficacy is summarised by Cochrane review: https://t.co/iFT06OEjY7
@traceyglazebro1 @DivineVision9 @DrJessTaylor Intermittent dosing of SSRIs in PMDD is supported by existing research and considered to be as effective as continuous dosing https://t.co/W6BfzMQao9
@DrJessTaylor Recommend by NICE… Side effects frequent but effective in reducing symptoms https://t.co/4diTyi9sCI
@DrJessTaylor Luteal phase therapy actually does have evidence to support it. As a pharmacist, I had concerns too knowing the potential for ADE/withdrawal with alternative diagnoses, but as someone with PMDD and luteal phase therapy, I can tell you it does
@f_hieronymus @EikoFried @MkRBol @DrGipps Also in this Cochrane review https://t.co/1ebjvLW8HN
@VanessaHawes PMDD is a disorder in which severity may vary. The efficacy of selective serotonin reuptake inhibitors (SSRIs) in the treatment of the severe PMDD was shown in numerous researches (https://t.co/higR7qhFfo , https://t.co/0KlpcGJPvc, https://t.
@ThePmddBlog Several individual trials and a meta-analysis have reported that SSRIs are equally effective for PMDD symptom relief whether taken continuously or only in the luteal phase. https://t.co/68x9nyhNfT
2013 Cochrane review of SSRIs for premenstrual syndrome https://t.co/atI4JMo6yD
ここ数年でわかってきた話だからこれからもっと情報出そう。 Selective serotonin reuptake inhibitors for premenstrual syndrome. - PubMed - NCBI https://t.co/o0opzxBNCC
@acognews What's new? I thought we'd known this for years. http://t.co/8z4ZV899kO
Selective serotonin reuptake inhibitors (SSRIs) for premenstrual syndrome http://t.co/G3hEEnh79t Cochrane review